Thromboprophylaxis for children hospitalized with COVID‐19 and MIS
Por um escritor misterioso
Descrição
Frontiers Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland
Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C - ScienceDirect
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
SciELO - Brasil - Proposed recommendations for antithrombotic prophylaxis for children and adolescents with severe infection and/or multisystem inflammatory syndrome caused by SARS-CoV-2 Proposed recommendations for antithrombotic prophylaxis for
Post-SARS-CoV-2 Multisystemic Syndrome in the Paediatric Population of Pakistan: A Case Report - European Medical Journal
Johns Hopkins All Children's Launches Study of Anti-clotting Medications' Impact on COVID-19 Patients
A guide to immunotherapy for COVID-19
Management of Multisystem Inflammatory Syndrome in Children Associated With COVID-19: A Survey From the International Kawasaki Disease Registry - ScienceDirect
MIS-C Associated with COVID-19 Anti-thrombosis Guideline of Care for Children - Advanced Cardiac Therapies Improving Outcomes Network
de
por adulto (o preço varia de acordo com o tamanho do grupo)
